Showing results (611-620 of 634) with videos related to

Sort By:
Pageof 64
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2019
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled TrialYong Sang Hong, Sun Young Kim, Ji Sung Lee, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2013
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancerKyung-Hun Lee, Hye Jung Chang, Sae-Won Han, et al.
Molecular Cancer Therapeutics|September 10, 2015
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityJae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, et al.
Cancer Research and Treatment|December 14, 2021
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
Investigational New Drugs|January 29, 2014
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximabJeeyun Lee, Yong Sang Hong, Jung Yong Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid TumorsTae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Clinical Colorectal Cancer|September 12, 2014
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensusAnn-Lii Cheng, Jin Li, Ashok K Vaid, et al.
Investigational New Drugs|May 29, 2020
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cellsSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
British Journal of Cancer|April 5, 2019
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutationsJai-Hee Moon, Seung-Woo Hong, Jeong Eun Kim, et al.
Anticancer Research|March 29, 2022
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal CancerJun Ki Hong, DO Yeon Kim, Jae-Sik Shin, et al.
Pageof 64